Tri-Heal Max Protocol
Also known as: Tri-Heal Max, THM, Enhanced Wolverine Stack
High-Dose Three-Peptide Healing Blend
Overview
Tri-Heal Max is an enhanced healing peptide blend featuring a higher dose of TB-500 (25mg) combined with BPC-157 (10mg) and KPV (10mg) for a total of 45mg per vial. This formulation emphasizes TB-500's tissue repair and cellular migration properties, complemented by BPC-157's growth factor upregulation and KPV's anti-inflammatory effects. The higher TB-500 ratio (2.5:1:1) compared to standard healing stacks targets more significant tissue damage or accelerated recovery needs.
Key benefits
- Enhanced TB-500 dosing for significant injuries
- Multi-pathway tissue regeneration
- Anti-inflammatory effects from KPV
- Complementary healing mechanisms
- Single injection convenience
- May accelerate recovery from surgery or injury
- Targets both acute and chronic tissue damage
Mechanism of action
Each peptide contributes distinct healing pathways: TB-500 (Thymosin Beta-4) enhances cellular migration, promotes actin polymerization, and supports blood vessel formation for tissue repair; BPC-157 upregulates growth factors (VEGF, EGF), accelerates wound healing, and provides gastrointestinal protection; KPV (alpha-MSH fragment) inhibits the NF-κB inflammatory pathway, reduces pro-inflammatory cytokines, and may improve injection site tolerability. Together, they address inflammation, tissue regeneration, and cellular repair.
Molecular data
- Type
- Fixed-ratio peptide combination
Sequence
TB-500 + BPC-157 + KPV (2.5:1:1 ratio)
Blend composition
What is in the vial, and in what proportion. Each component has its own reference page.
Total 45 mg per vial.
Indications
What the research community uses this compound for, with self-reported effectiveness.
Tissue Healing
Significant Injuries
EffectiveHigher TB-500 dose targets more severe tissue damage requiring enhanced repair.
Muscle Tears & Strains
EffectiveTB-500 promotes muscle fiber repair and cellular migration.
Tendon & Ligament Repair
EffectiveCombined collagen support and growth factor upregulation.
Post-Surgical Recovery
Wound Healing
EffectiveMulti-modal support for surgical wound recovery.
Reduced Inflammation
ModerateKPV component reduces post-surgical inflammatory response.
Scar Reduction
ModerateEnhanced tissue remodeling may reduce scar formation.
Sports Medicine
Athletic Recovery
EffectiveAccelerated return to activity after sports injuries.
Chronic Overuse Injuries
ModerateAddress accumulated tissue damage from repetitive stress.
Dosing protocols
Common protocols by delivery method. Adjust the curve below to model accumulation in your own cycle.
Injectable
Subcutaneous injection is the primary delivery method. Can inject near injury site or systemically. The higher TB-500 content makes this suitable for more significant healing needs.
| Protocol | Dose | Frequency | Route / duration |
|---|---|---|---|
| Conservative healing | 200-300mcg total blend | Once daily | SubQ |
| Standard healing protocol | 300-500mcg total blend | Once daily | SubQ |
| Intensive healing (acute injury) | 500mcg total blend | Once daily for first 2 weeks, then reduce | SubQ near injury site |
| Cycling protocol | Per standard dosing | 4-6 weeks on, 2-4 weeks off | SubQ |
Preparation
You will need
- Tri-Heal Max 45mg vial
- Bacteriostatic water (2-4mL)
- Insulin syringes
- Alcohol prep pads
Steps
- Clean vial top with alcohol pad
- Add 2mL bacteriostatic water (creates 22.5mg/mL)
- Gently swirl - do not shake
- Solution should appear clear
- Label with date and concentration
- Store refrigerated immediately
- Use within 4-6 weeks
Work out the water volume and syringe units in the reconstitution calculator →
Interactions
Pairwise interactions with other compounds you might be cycling — the same data behind the cycle builder's safety check.
Wolverine Stack (BPC/TB)
AvoidTri-Heal Max already contains BPC-157 and TB-500 - do not stack.
KLOW/GLOW Protocol
AvoidContains overlapping components (TB-500, BPC-157, KPV) - avoid combining.
Growth Hormone
MonitorMultiple anabolic/healing pathways - medical supervision recommended.
Anticoagulants
MonitorTB-500 affects blood vessel formation; monitor with blood thinners.
GHK-Cu
CompatibleComplementary healing mechanisms; GHK-Cu adds copper-peptide benefits.
Ipamorelin/CJC-1295
CompatibleDifferent mechanisms; GH secretagogues may complement healing.
Timeline
Typical week-by-week effects reported in clinical and observational data.
- Days 1-5
Anti-inflammatory effects from KPV; initial healing cascade activation
- Week 1-2
Tissue repair processes accelerating; reduced inflammation
- Week 2-4
Significant healing progress; collagen remodeling
- Week 4-8
Advanced tissue regeneration; assess for cycling off
Safety
Reported adverse effects, contraindications, and what to monitor on cycle.
Common side effects
- Injection site reactions (KPV may help reduce these)
- Mild fatigue during healing
- Temporary redness at injection site
Rare side effects
- Headache
- Lightheadedness
- Flu-like symptoms
Stop signs — stop and seek advice
- Severe injection site reactions or signs of infection
- Allergic reactions (rash, swelling, difficulty breathing)
- Unusual bleeding or bruising
- Worsening of underlying conditions
Contraindications
- No clinical trials on this three-peptide combination
- Active cancer (theoretical concern with growth-promoting peptides)
- Pregnancy or breastfeeding
- Active infection at injection site
Monitoring
- Healing progress of target injury
- Injection site reactions
- General recovery and energy levels
- Any unusual symptoms
Quality checks
What a legitimate product looks like, what should give pause, and what should make you stop.
Good signs
- Third-party testing confirming all three components
- Certificate of Analysis with ratios verified
- Reputable research supplier
- Proper cold chain shipping
Warning signs
- Research-only status - not approved for human use
- Batch variability possible in ratios
Stop signs — don't use
- No Certificate of Analysis
- Cannot verify TB-500:BPC:KPV ratio
- Discolored or particulate solution
References
Primary literature and clinical-trial data informing this entry.
Thymosin Beta-4 (TB-500) Tissue Repair
Multiple Studies
TB-500 promotes cell migration, blood vessel formation, and wound healing through actin modulation.
BPC-157 Healing Properties
Current Pharmaceutical Design
BPC-157 upregulates growth factors and accelerates healing of various tissue types.
KPV Anti-Inflammatory Effects
Peptide Research
KPV (alpha-MSH 11-13) inhibits NF-κB pathway and reduces pro-inflammatory cytokines.
No Published Studies on Tri-Heal Max Combination
2024
Specific three-peptide combination has not been studied in clinical trials.
Last updated . How this page was sourced is described in the methodology.